. 2016 May 19;5(1):81–94. doi: 10.1007/s40123-016-0053-7

Table 2.

Prior laser therapy, co-pathologies, and CRT and BCVA at referral (baseline) and most recent measure (post-laser) in pseudophakic patients and patients with unknown lens status (e.g., may be pseudophakic) with diabetic macular oedema who had received more than one prior laser therapy

Eye	Pseudophakic/unknown	Co-pathologies	Laser	CRT at referral (µm)	Most recent CRT (µm)	Change in CRT from baseline (µm)	BCVA at referral (letters)	Most recent BCVA (letters)	Change in BCVA from baseline (µm)	Failed laser, consider for 0.2 μg/day FAc implant
1	Pseudophakic		2	325	348	23	90	70	−20	Y
2	Pseudophakic	BRVO, CRVO	2	342	219	−123	70	61	−9	N
3	Pseudophakic		6	431	246	−185	70	68	−2	N
4	Pseudophakic		4	318	304	−14	75	59	−16	Y
5	Pseudophakic		2	317	318	1	60	45	−15	Y
6	Pseudophakic		3	249	226	−23	75	82	7	N
7	Pseudophakic		4	211	262	51	85	74	−11	Y
8	Pseudophakic		2	266	346	80	70	44	−26	Y
9	Pseudophakic		2	250	269	19	75	42	−33	Y
10	Pseudophakic	FED	2	245	259	14	75	70	−5	Y
11	Pseudophakic	FED	2	257	300	43	75	75	0	Y
12	Pseudophakic		3	392	268	−124	55	55	0	Y
13	Pseudophakic		3	275	264	−11	75	70	−5	Y
14	UNK		2	228	227	−1	60	75	15	N^a
15	UNK		3	290	352	62	85	70	−15	N^a
16	UNK		2	264	265	1	85	75	−10	N^a
17	UNK		3	265	270	5	85	75	−10	N^a
18	UNK		4	288	260	−28	75	75	0	N^a
19	UNK		2	262	270	8	70	70	0	N^a
20	UNK		4	250	337	87	60	60	0	N^a
21	UNK		4	268	368	100	85	70	−15	N^a
22	UNK	HZ keratitis	4	279	264	−15	85	70	−15	N^a
23	UNK	Amblyopia	3	283	362	79	55	60	5	N^a
24	UNK		2	419	291	−128	95	60	−35	N^a
25	UNK		2	254	290	36	90	58	−32	N^a
26	UNK		2	259	277	18	85	64	−21	N^a
27	UNK		2	277	309	32	90	75	−15	N^a
28	UNK		3	265	263	−2	90	80	−10	N^a
Overall mean (±SD)				286.8 (53.3)	286.9 (41.8)	+0.2 (68.1)	76.6 (11.4)	66.1 (10.5)	−10.5 (12.2)	N = 28 eyes
Mean (±SD) in pseudophakic laser failures				285.6 (52.4)	293.8 (34.6)	+8.2 (54.7)	73.5 (10.3)	60.4 (13.1)	−13.1 (11.1)	N = 10 eyes
Mean (±SD) in pseudophakic laser successes				340.7 (91.0)	230.3 (14.0)	−110.3 (81.7)	71.7 (2.9)	70.3 (10.7)	−1.3 (8.0)	N = 3 eyes

BCVA best-corrected visual acuity, BRVO branch retinal vein occlusion, CRT central retinal thickness, CRVO central retinal vein occlusion, FAc fluocinolone acetonide, FED Fuch’s endothelial dystrophy, HZ herpes zoster, N no, SD standard deviation, UNK unknown, Y yes

^aUNK patients are considered unsuitable for 0.2 μg/day FAc implant, as they are assumed to be phakic (recent cataract surgeries are recorded on Medisoft^®)